Difficulty: Medium
Average Score: 66%
Practice
To be a useful inhaled glucocorticoid the drug should have
Correct answer
B
Rationale
In the context of respiratory drugs, inhaled glucocorticoids are crucial in managing conditions like asthma and chronic obstructive pulmonary disease (COPD). The correct answer to the question is B) Low oral bioavailability.
Inhaled glucocorticoids are designed to have low oral bioavailability. This means that when taken orally, these drugs are poorly absorbed into the bloodstream, reducing systemic side effects. However, when inhaled directly into the lungs, they exert their anti-inflammatory effects locally, reducing airway inflammation and symptoms.
Option A) High oral bioavailability is incorrect because high oral bioavailability would lead to increased systemic absorption, resulting in a higher risk of systemic side effects associated with glucocorticoid use.
Option C) Additional bronchodilator activity is not a requirement for inhaled glucocorticoids. These drugs primarily work by reducing inflammation in the airways rather than directly causing bronchodilation.
Option D) Prodrug character is also not a necessary characteristic for inhaled glucocorticoids. Prodrugs require conversion to their active form in the body before exerting their therapeutic effects, which is not a requirement for inhaled glucocorticoids.
Understanding the properties of inhaled glucocorticoids is essential for healthcare professionals to ensure effective treatment of respiratory conditions while minimizing systemic side effects. By selecting the appropriate delivery method and understanding drug characteristics, healthcare providers can optimize patient outcomes and quality of life.
Inhaled glucocorticoids are designed to have low oral bioavailability. This means that when taken orally, these drugs are poorly absorbed into the bloodstream, reducing systemic side effects. However, when inhaled directly into the lungs, they exert their anti-inflammatory effects locally, reducing airway inflammation and symptoms.
Option A) High oral bioavailability is incorrect because high oral bioavailability would lead to increased systemic absorption, resulting in a higher risk of systemic side effects associated with glucocorticoid use.
Option C) Additional bronchodilator activity is not a requirement for inhaled glucocorticoids. These drugs primarily work by reducing inflammation in the airways rather than directly causing bronchodilation.
Option D) Prodrug character is also not a necessary characteristic for inhaled glucocorticoids. Prodrugs require conversion to their active form in the body before exerting their therapeutic effects, which is not a requirement for inhaled glucocorticoids.
Understanding the properties of inhaled glucocorticoids is essential for healthcare professionals to ensure effective treatment of respiratory conditions while minimizing systemic side effects. By selecting the appropriate delivery method and understanding drug characteristics, healthcare providers can optimize patient outcomes and quality of life.